Potter, Vice President of Corporate Advancement for Genzyme.’ challenged Mary Tyler Moore.’ Awards were presented to Mark Atkinson, Co-director of the Diabetes Research Middle at the University of Florida and Dr. Paul Lacy, who 30 years ago performed the first effective islet transplant in an pet. Lacy’s important function was the precursor to the Edmonton Process, in which 30 years later on seven sufferers received islet transplants successfully. ‘In the a lot more than four years since the initial trial outcomes of the Edmonton Process were announced, only about 300 additional individuals have undergone the procedure. To us at JDRF, that small number is a minimum of heartbreaking.’ questioned Van Etten. JDRF was founded in 1970 by the parents of kids with juvenile diabetes – a disease that strikes children abruptly, makes them dependent for life insulin, and carries the constant threat of devastating problems.The Roundtable discussion helps put AYA malignancy in perspective for those who have not however considered the 15-39 year old cancer patient as a definite and relevant affected individual group, relating to Editor-in-Chief Leonard S. Sender, MD, of the University of California, Irvine and CHOC Children’s Medical center. The roundtable conversation, Trailblazers in Adolescent and Youthful Adult Oncology, was moderated by Archie Bleyer, MD, Medical Director of Clinical Analysis for the St. Charles Health System in Bend, Oregon. Individuals were leading physicians of pediatric, adolescent, and young adult oncology who have helped mold and advance this area of specialization trace the annals and traveling forces behind programs and disease administration strategies now in place that target this individual population.